KalVista Pharmaceuticals logo
KalVista Pharmaceuticals KALV
$ 9.99 7.18%

Quarterly report 2023-Q4
added 03-11-2024

report update icon

KalVista Pharmaceuticals Deferred Revenue 2011-2024 | KALV

Annual Deferred Revenue KalVista Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - 9.54 M 18.5 M - - 29 K 29 K 29 K 23 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
18.5 M 23 K 4.69 M

Quarterly Deferred Revenue KalVista Pharmaceuticals

2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - - 1.34 M - - - 12.3 M 2.6 M 6.02 M 9.54 M 20 M 14.8 M 17.2 M 18.5 M - - - - - 29 K 29 K 29 K 29 K 29 K 29 K 29 K 29 K 29 K 29 K - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
20 M 29 K 5.4 M